Neurology Archives - Page 9 of 10

Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia

Authors: S J Snedecor, M F Botteman, C Bojke, K Schaefer, N Barry, A S Pickard Published: Sleep, 2010 View publication Objective To assess the cost-effectiveness of treatment with eszopiclone for chronic...

Health economics of insomnia therapy: implications for policy

Authors: M F Botteman Published: Sleep Medicine, 2010 View publication Abstract Chronic primary insomnia is a major public health problem causing significant burden for those affected. Rising health care costs may cause...

Cost effectiveness of long-acting risperidone in Sweden

Authors: M Hensen, B Heeg, M Löthgren, B van Hout Published: European Journal of Health Economics, 2010 View publication Background In Sweden, risperidone long-acting injectable (RLAI) is generally used in a population...

Mapping of the insomnia severity index and other sleep measures to EuroQol EQ-5D health state utilities

Authors: N Y Gu, M F Botteman, X Ji, C F Bell, J A Carter, B van Hout Published: Health Quality of Life Outcomes, 2011 View publication Background This study sought to...

Modelling approaches: the case of schizophrenia

Authors: B M Heeg, J Damen, E Buskens, C Caleo, F de Charro, B A van Hout Published: Pharmacoeconomics, 2010 View publication Abstract Schizophrenia is a chronic disease characterized by periods of...

Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial

Authors: S J Snedecor, L Sudharshan, J C Cappelleri, A Sadosky, P Desai, Y J Jalundhwala, M Botteman Published: Journal of Medical Economists, 2013 View publication Background Surgical resection of gastrointestinal stromal...

Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores

Authors: N Y Gu, C Bell, M F Botteman, X Ji, J A Carter, B van Hout Published: The Patient, 2012 View publication Background Preference-based health state utilities are required for many...

The cost-effectiveness of paliperidone extended release in Spain

Authors: M Treur, E Baca, J Bobes, F Cañas, L Salvador, B Gonzalez, B Heeg Published: Journal of Medical Economists, 2012 View publication Background Paliperidone Extended Release OROS (ER) is a new...

Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury

Authors: S J Snedecor, L Sudharshan, J C Cappelleri, A Sadosky, P Desai, Y J Jalundhwala, M Botteman. Published: Journal of Pain Research, 2013 View publication Background Management of neuropathic pain (NeP)...

News